Monthly Archives: May 2018

Israeli researchers say new treatment could boost fertility in women and men

#MedicalScientists say single dose of compound developed at #Ben-GurionUniversity could speed up #eggmaturation and #ovulation By SHOSHANNA SOLOMON #Israeliresearchers say they may have found a new compound that can help #boostfertility in both men and women. #BGNTechnologies, the technology transfer company of Ben-Gurion University (BGU), said this week that researchers at the university are developing [...]

By |2018-11-20T09:45:37+00:00May 3rd, 2018|Blog|Comments Off on Israeli researchers say new treatment could boost fertility in women and men

Eye implants for glaucoma patients inspired by Butterfly wings

May 01, 2018  - RESEARCH Inspired by tiny structures on transparent #butterflywings, scientists have developed a light-#manipulatingsurface for more effective and longer-lasting #eyeimplants for #glaucoma patients. Sections of the wings of a #longtailglasswing #butterfly are almost perfectly transparent, according to the research published in the journal Nature #Nanotechnology. Researchers at California Institute of Technology [...]

By |2018-11-20T09:33:51+00:00May 3rd, 2018|Blog|Comments Off on Eye implants for glaucoma patients inspired by Butterfly wings

DSG TO ATTEND 17th MIXiii-BIOMED IN TEL AVIV, ISRAEL

MALVERN, Pa.|May 2, 2018 #DSG, Inc., an industry leader in #eClinicalsoftware and services to the life sciences industry will be exhibiting at the 17th #MIXiii-#BIOMED2018 Conference and Exhibition. The conference is set to take place May 15-17, 2018 in Tel Aviv, Israel at the David InterContinental Hotel. The MIXiii-BIOMED conference will further the knowledge of [...]

By |2018-11-20T09:46:11+00:00May 3rd, 2018|PR|Comments Off on DSG TO ATTEND 17th MIXiii-BIOMED IN TEL AVIV, ISRAEL

Israeli cancer profiling co NovellusDx raises $6m

NovellusDx CEO: The funds will let us move into commercialization and enable us to meet the need for functional oncology worldwide. #Israeli #functionalgenomics and #cancer profiling company #NovellusDx today announced it has completed a $6 million #financing round with the participation of Helsinn #InvestmentFund S.A. SICAR, part of Helsinn Group, a leading cancer care [...]

By |2018-11-20T09:34:20+00:00May 2nd, 2018|Blog|Comments Off on Israeli cancer profiling co NovellusDx raises $6m

FDA clears Pluristem radiation treatment for emergency use

Tova Cohen | Reuters Biologists work in a laboratory at Pluristem Therapeutics in Haifa. A laboratory worker removes cells from a storage unit at Pluristem Therapeutics in Haifa, Israel March 6, 2016. REUTERS/BAZ RATNER (Reuters) - Pluristem Therapeutics Inc, a developer of #placenta-based #stemcell products, said the U.S. Food and Drug Administration has cleared the [...]

By |2018-11-20T09:35:00+00:00May 2nd, 2018|Blog|Comments Off on FDA clears Pluristem radiation treatment for emergency use

United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

by Nick Paul Taylor | FierceBiotech | Apr 30, 2018 United #Therapeutics has struck a $216 million deal to buy #SteadyMed. The acquisition enables United to eliminate a potential threat by taking control of a #startup that has been fighting to invalidate its patents and mount a #pump-based attack on its #pulmonaryarterialhypertension (PAH) #franchise. SteadyMed’s pitch for the [...]

By |2018-11-20T09:36:11+00:00May 2nd, 2018|Blog|Comments Off on United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

Measuring glucose without need for finger-prick blood test

APRIL 11, 2018 | NanoMagazine Scientists at Bath University have developed a wearable sensor that measures glucose levels through the skin, an advance that could mark the end of finger-prick blood tests for diabetics. The non-invasive patch is said to draw glucose from fluid between cells across hair follicles, which are accessed via an array of [...]

By |2018-11-20T09:36:28+00:00May 1st, 2018|Blog|Comments Off on Measuring glucose without need for finger-prick blood test